Prescient Therapeutics Ltd (ASX: PTX)

Share Purchase Plan Opportunity

Request Share Purchase Plan Form

What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach* provides Corporate Advisory Services, including managing investor communications on behalf of Prescient Therapeutics Limited and may receive fees for its services.

Reach Markets Pty Ltd provide Corporate Advisory Services to Prescient Therapeutics Limited and will receive fees for managing this offer based on the uptake by investors.

Reach Investment Group Nominees Pty Ltd, a related entity of Reach Markets, holds options in Prescient Therapeutics Limited.

The Share Purchase Plan (SPP) is not an offer of securities in any place outside Australia or New Zealand and does not take into account your individual investment objectives, financial situation or particular needs. An investment in the Company is speculative. The information in the SPP Booklet is not investment advice or a recommendation to acquire SPP Shares. Therefore, you should obtain independent financial and taxation advice before making an investment decision. Before making an investment decision, you should read the SPP terms in the Offer Booklet.

This investor centre was built by Reach Markets

©2026 Reach Markets

×

Do you qualify as a Wholesale (708) investor?

Wholesale 708 Sophisticated Investors are individuals or entities who generally qualify under Sections 708(8) and s761G(7) of the Corporations Act based on the gross income and/or net assets test verified by a qualified accountant.
  • A gross income of $250,000 or more per annum in each of the previous two financial years; or
  • Net assets of at least $2.5 million; and
  • A verified Qualified Accountant’s certificate given no more than two (2) years ago confirming the Sophisticated Investor status. Please refer to the Corporations Act: Specifically Section 708(08) and Section s761G(7)
×

Any advice is general only

Any advice provided by Reach Markets, the Lead Manager on this offer, including on its website and by its representatives is general advice only and does not consider your objectives, financial situation or needs, and you should consider whether it’s appropriate for you. This might mean that you need to seek personal advice from a representative authorised to provide personal advice.

×

Receive email updates

What is a 708 investor?

By submitting this form, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement. Reach Markets provides Corporate Advisory Services, including managing investor communications on behalf of Prescient Therapeutics Limited and may receive fees for its services.